Testosterone changes with age, but your own result matters more than an average. This guide explains the ranges, the symptoms worth checking and what to do next.
Heracles brings testing and clinician review together to help you understand your hormone health. Check your testosterone with Heracles.
In adult men, total testosterone tends to be higher in early adulthood and may decline with age, while sex hormone-binding globulin often rises and free testosterone may fall more quickly. That trend is real, but it is not a universal timetable and does not create a separate do-it-yourself treatment threshold for each birthday.
A widely cited harmonised study found a total-testosterone reference interval of 264-916 ng/dL, approximately 9.2-31.8 nmol/L, in healthy non-obese men aged 19-39. That is a research reference interval for a selected population measured with standardised methods. It is not an "optimal" target, and it should not be applied uncritically to every laboratory or older man.
For UK clinical assessment, the more relevant framework uses compatible symptoms, correctly collected repeat tests and cause-finding. The joint Society for Endocrinology and Association for Laboratory Medicine position statement treats two morning, fasting results below 8 nmol/L as likely hypogonadism in a symptomatic man; 8-12 nmol/L as a borderline zone; and a correctly collected result above 12 nmol/L as not usually consistent with hypogonadism. These are action cut-offs for assessment, not age-specific reference ranges or automatic prescribing rules.
A laboratory reference range describes results in a reference population. A clinical threshold helps a doctor decide whether further assessment is needed. Your result is interpreted using the reporting laboratory’s range, your symptoms and repeat testing where appropriate.
Population averages describe a group. Treatment targets apply after diagnosis and take account of the treatment, sampling time and safety checks.
| Age or life stage | What the evidence can tell us | Important limitation |
|---|---|---|
| Childhood and puberty | Testosterone changes substantially with pubertal stage and must be interpreted using paediatric methods and reference intervals | Adult ranges and adult TRT thresholds do not apply |
| 19-39 years | A harmonised study of healthy non-obese European and US men reported 264-916 ng/dL, about 9.2-31.8 nmol/L, as the 2.5th-97.5th percentile interval | This selected research population is not a universal UK diagnostic range or an "optimal" band |
| 20-44 years | A US study proposed age-specific low-testosterone cut-offs for younger men, from about 409 ng/dL at 20-24 to 350 ng/dL at 40-44 | These proposed cut-offs are not a replacement for current UK diagnostic guidance, local assays, symptoms or repeat testing |
| 40-79 years | European data show gradual average change, with free testosterone declining faster than total testosterone as SHBG rises | A group trend cannot distinguish healthy ageing from obesity, illness, medicine effects or organic hypogonadism in an individual |
| Later life | Lower results and comorbidity become more common, but marked deficiency may still reflect testicular or pituitary disease | Age should not be used to dismiss a well-founded diagnosis or to medicalise nonspecific symptoms automatically |
The familiar "1% per year" phrase is a rough population summary, not a biological countdown for every man. The current European Association of Urology guideline cites European Male Ageing Study estimates of an average 0.4% annual decline in total testosterone and a 1.3% annual decline in free testosterone. The difference is partly explained by rising SHBG.
Those averages combine men with different health trajectories. Weight gain, insulin resistance, chronic disease, medicines, sleep problems and reduced physical activity can contribute to the apparent age relationship. Longitudinal research suggests that accumulating illness and obesity may account for much of the fall often attributed to age alone.
One man may remain stable over years. Another may have a temporary fall during illness or under-fuelling. A third may develop true primary testicular failure or a pituitary disorder. Age is relevant background, not the diagnosis.
Not automatically. Older age makes lower total and free testosterone more common, but it does not make clinically important hypogonadism harmless or inevitable. Conversely, an older man with fatigue and a low-normal result does not automatically benefit from TRT.
The decision still turns on:
For morning, fasting samples in symptomatic adult men, the joint UK position statement provides a practical interpretation:
| Total testosterone result | General clinical interpretation |
|---|---|
| Below 8 nmol/L on two separate tests | Hypogonadism is likely, subject to clinical assessment and investigation of the cause |
| 8-12 nmol/L | Borderline: interpret symptoms, SHBG, calculated free testosterone where indicated, assay context and related hormones |
| Above 12 nmol/L | Not usually consistent with hypogonadism; one correctly collected result above this level will usually exclude it |
The EAU uses 12 nmol/L as a clinical threshold for symptomatic late-onset hypogonadism and recommends repeating a result below that level before treatment. BSSM guidance uses a related framework but includes treatment recommendations that should be applied by an appropriately qualified clinician, not copied into a consumer eligibility quiz.
Different guidance can use different wording because reference intervals, diagnostic thresholds and treatment thresholds answer different questions. Any threshold should be identified and explained rather than presented as a single settled number.
Different assays and reference populations can produce different ranges. Use the reporting laboratory’s units and reference information when reviewing your result. Your clinician can compare reports from different laboratories.
Most circulating testosterone is bound to SHBG or albumin. Only a small fraction is unbound. As SHBG often rises with age, total testosterone can appear relatively preserved while calculated free testosterone falls.
That does not mean free testosterone should replace total testosterone in every case. The UK joint position statement says calculated free testosterone usually adds little when SHBG is within range. It may be helpful when SHBG is high, because total testosterone can look reassuring despite a low calculated free fraction, or when SHBG is low, because total testosterone can look low despite an adequate free fraction.
The laboratory method matters. Equilibrium dialysis followed by mass spectrometry is considered the reference method for free testosterone but is not routinely available in UK practice. Many direct free-testosterone immunoassays are inaccurate. A calculated result is an estimate derived from total testosterone, SHBG and usually albumin.
Interpretation should account for factors that can suppress testosterone temporarily or persistently:
Some of these factors change SHBG as well as testosterone. The pattern across total testosterone, SHBG, calculated free testosterone, LH and FSH is often more informative than one number viewed alone.
A high result is not automatically a sign of better health. It may reflect a high SHBG level, prescribed testosterone sampled at a particular point in the dosing cycle, non-medical androgen use, a supplement containing undeclared hormones, assay interference or, less commonly, an underlying condition.
Men using prescribed TRT should follow formulation-specific sampling instructions. Comparing a post-dose peak with an untreated morning reference interval can create a false impression. Unexpectedly high natural or treated results should be reviewed with the prescriber rather than "balanced" with another medicine or supplement.
Share the full report with your clinician, including sample timing, symptoms, medicines and any fertility plans. A low result is usually repeated on a separate morning. Further tests help explain the cause and guide the right care.
Heracles was co-founded by Professor Suks Minhas and Professor Tet Yap. Our team brings together expertise in urology, andrology, endocrinology, nutrition and sexual health. Meet the specialists behind your care.
Check your testosterone with Heracles.
On average, yes. SHBG often rises with age, and European data show a faster decline in free than total testosterone. The individual result still depends on health, body composition, assay and clinical context.
No. Most men do not experience a universal "male menopause," and TRT is not routine anti-ageing treatment. It is considered when a man has compatible symptoms, confirmed biochemical deficiency and a cause for which treatment is appropriate.
